Atria Wealth Solutions Inc. Increases Stake in HCA Healthcare, Inc. (NYSE:HCA)

Atria Wealth Solutions Inc. lifted its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 50.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,529 shares of the company’s stock after acquiring an additional 851 shares during the period. Atria Wealth Solutions Inc.’s holdings in HCA Healthcare were worth $685,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Stone House Investment Management LLC purchased a new position in HCA Healthcare during the 3rd quarter worth approximately $25,000. Centerpoint Advisors LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $27,000. Bruce G. Allen Investments LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at approximately $28,000. BluePath Capital Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $27,000. Finally, Annis Gardner Whiting Capital Advisors LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $30,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In related news, SVP Chad J. Wasserman sold 344 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at $789,470.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Sammie S. Mosier sold 1,645 shares of the business’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the sale, the senior vice president now owns 7,646 shares in the company, valued at $2,385,552. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,127 shares of company stock worth $2,218,364. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Truist Financial lifted their target price on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. TD Cowen dropped their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Barclays lifted their price target on shares of HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. Finally, Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $316.59.

Get Our Latest Stock Report on HCA

HCA Healthcare Stock Down 0.3 %

NYSE HCA opened at $307.76 on Friday. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The business’s fifty day simple moving average is $322.22 and its 200-day simple moving average is $297.73. The firm has a market cap of $81.40 billion, a PE ratio of 15.34, a P/E/G ratio of 1.44 and a beta of 1.66.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.93 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 20.74 earnings per share for the current year.

HCA Healthcare declared that its Board of Directors has approved a share buyback program on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in shares. This buyback authorization authorizes the company to purchase up to 7.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.